This module has been developed to support the knowledge of practising clinicians interested in repurposing drugs in oncology.
By the end of this module you should be able to:
Identify that repurposing is efficient and cost-effective, assuming we can prove efficacy
Be familiar with the many cancer related mechanisms of action that nitroglycerin has
Understand that reducing hypoxia with nitroglycerin can increase the therapeutic effect of existing chemo and chemoradiation protocols
Understand that additional clinical trials of nitroglycerin are warranted
This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.
If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.
If you are experiencing technical difficulties, please contact firstname.lastname@example.org and we will get back to you as soon as possible.
ecancer and Dr Pan Pantziarka, PhD, Anticancer Fund, Strombeek-Bever, Belgium have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this Re-DO e-learning module. We have no disclosures to report in relation to this project.